Id |
Subject |
Object |
Predicate |
Lexical cue |
T245 |
0-358 |
Sentence |
denotes |
The antiviral innate immune signaling pathways are regulated by several posttranslational modifications (PTMs), such as phosphorylation, ubiquitination, glycosylation, NEDDylation and SUMOylation [187], of which ubiquitination is a critical modification to modulate the stability and activity of PRRs and other components of innate immune signaling pathways. |
T246 |
359-514 |
Sentence |
denotes |
During viral infection, a reciprocatory action (occurrence of ubiquitination and deubiquitination) helps maintain the homeostasis of host immune responses. |
T247 |
515-625 |
Sentence |
denotes |
Hence, deubiquitinases (DUBs) are indispensable in the regulation of virus-induced type I IFN signaling [188]. |
T248 |
626-737 |
Sentence |
denotes |
Many host DUBs have been reported engaging in the regulation of innate immune signaling pathways [189,190,191]. |
T249 |
738-883 |
Sentence |
denotes |
In recent years, a variety of viral DUBs have been discovered to target key components of type I IFN pathway during various RNA virus infections. |
T250 |
884-1127 |
Sentence |
denotes |
For example, foot-and-mouth disease virus leader proteinase (FMDV Lbpro) [192], and porcine reproductive and respiratory syndrome virus nsp2 (PRRSV nsp2) possess ubiquitin-deconjugating activity to deubiquitinate key host components [193,194]. |
T251 |
1128-1240 |
Sentence |
denotes |
To counteract host antiviral response, CoVs likely take advantage of DUB activity to break host innate immunity. |
T252 |
1241-1388 |
Sentence |
denotes |
Indeed, the PLPs of mouse hepatitis virus A59 (MHV-A59) [195], SARS [196], and human CoV NL63 have DUB activity and antagonize IFN induction [197]. |
T253 |
1389-1517 |
Sentence |
denotes |
PEDV PLP2 has been reported as having a deubiquitinase activity as well, and it can be co-immunoprecipitated by RIG-I and STING. |
T254 |
1518-1687 |
Sentence |
denotes |
As mentioned above, FMDV Lbpro, MHV PLP2 and SARS PLPs all counteract host innate immune response through blocking the ubiquitination of the components of RLRs pathways. |
T255 |
1688-1833 |
Sentence |
denotes |
Similarly, PEDV PLP2 removes the ubiquitinated conjugates from RIG-I and STING by its DUB activity, to negatively regulate type I IFN production. |
T256 |
1834-1997 |
Sentence |
denotes |
PEDV PLP2 probably interacts with RIG-I and STING, which prevents the activation of RIG-I and STING by hindering the recruitment of downstream signaling molecules. |
T257 |
1998-2118 |
Sentence |
denotes |
As expected, the interference with the ubiquitination of RIG-I and STING by PLP2 clearly benefits PEDV replication [80]. |
T258 |
2119-2179 |
Sentence |
denotes |
PEDV nsp3 contains two core domains of PLPs (PLPl and PLP2). |
T259 |
2180-2283 |
Sentence |
denotes |
It is determined that PEDV PLP2, but not PLP1, inhibits the IFN-β promoter activation in HEK293T cells. |
T260 |
2284-2355 |
Sentence |
denotes |
The DUB activity of PLP2 is highly dependent on its catalytic activity. |
T261 |
2356-2537 |
Sentence |
denotes |
Three catalytically inactive mutants of PEDV PLP2 (C1729A, H1888A and D1901A) are defective in the deubiquitination of its targets and fail to impair virus-induced IFN-β production. |